Karim Mahawish

Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial

Martin Dennis, Gillian Mead, John Forbes et al. · The Lancet · 2018 · 276 citations · Full text

Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study

Duncan Wilson, Gareth Ambler, Clare Shakeshaft et al. · The Lancet Neurology · 2018 · 248 citations · Full text

Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial

Graeme J. Hankey, Maree L. Hackett, Osvaldo P. Almeida et al. · The Lancet Neurology · 2020 · 139 citations · Full text

Cerebrovascular Disease, Placebo-controlled Trial, Functional Outcome +19

Switching to Tenecteplase for Stroke Thrombolysis

Karim Mahawish, John Gommans, Timothy Kleinig et al. · Stroke · 2021 · 74 citations · Full text

Small Vessel Disease and Ischemic Stroke Risk During Anticoagulation for Atrial Fibrillation After Cerebral Ischemia

Houwei Du, Duncan Wilson, Gareth Ambler et al. · Stroke · 2020 · 58 citations · Full text